Share this page on LinkedIn
Share This Page on Google+
Share This Page on Twitter
tell someone about this page print this page
You are here: Contents > 2016 > Volume 25 Number 5 September 2016 > AORTIC VALVE DISEASE > The Impact of Gender on Outcomes Following Transcatheter Aortic Valve Implantation: True Effect or Bias?

The Impact of Gender on Outcomes Following Transcatheter Aortic Valve Implantation: True Effect or Bias?

Vasileios F. Panoulas1,2,5, Neil Ruparelia1,2, Russel Franks2, Sayan Sen1,2, Ben Ariff3, Nilesh Sutaria1,2, Angela Frame2, Petros Nihoyannopoulos1,2, Iqbal S. Malik1,2, Ghada W. Mikhail1,2

1Cardiovascular Sciences, National Heart and Lung Institute, Imperial College London, London, UK
2Cardiology Department, National Heart and Lung Institute, Imperial College London, London, UK
3Radiology Department, National Heart and Lung Institute, Imperial College London, London, UK
4Department of Cardiothoracic Surgery, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK
5Electronic correspondence: v.panoulas@imperial.ac.uk

Transcatheter aortic valve implantation (TAVI) is currently the treatment of choice for patients with severe aortic stenosis (AS) who are unsuitable for surgical aortic valve replacement (SAVR), and is an acceptable alternative for those at high and intermediate surgical risk. In published TAVI registries and meta-analyses, whilst women are significantly older they present with fewer comorbidities compared to men (including coronary artery disease, peripheral vascular disease, diabetes and chronic obstructive pulmonary disease). In response to chronic pressure overload from AS, women have been shown to develop greater levels of left ventricular hypertrophy than

 

men, as well as having a greater preservation of LV ejection fraction (LVEF) and less fibrosis. Following aortic valve replacement, women have been shown to have a faster regression of myocardial hypertrophy, with a significant improvement in LVEF. Following TAVI, female gender seems to be associated with a significantly lower one-year mortality. In the current viewpoint, it is discussed whether these findings reflect a true differential treatment response to TAVI among women, or simply the higher comorbidity burden among males undergoing TAVI

The Journal of Heart Valve Disease 2016;25:552-556


The Impact of Gender on Outcomes Following Transcatheter Aortic Valve Implantation: True Effect or Bias?

Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.

Purchase this Article

Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.